2-Chloro-5-(phenylmethanesulfonylmethyl)-1,3-thiazole

Catalog No.: 
ACXYPO533
CAS No.: 
866039-47-6
Molecular Formula: 
C11H10ClNO2S2
Molecular Weight: 
287.79
2-Chloro-5-(phenylmethanesulfonylmethyl)-1,3-thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$111.00InquiryInquiry
1g90%$325.00InquiryInquiry
5g90%$1609.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-5-(phenylmethanesulfonylmethyl)-1,3-thiazole
IUPAC Name5-((benzylsulfonyl)methyl)-2-chlorothiazole
MDL No.MFCD03787739
Molecular FormulaC11H10ClNO2S2
Molecular Weight287.79
SMILESO=S(CC1=CN=C(Cl)S1)(CC2=CC=CC=C2)=O
InChI KeyPPCDZIRJJBVTIF-UHFFFAOYSA-N
SynonymBENZYL (2-CHLORO-1,3-THIAZOL-5-YL)METHYL SULFONE;5-[(BENZYLSULFONYL)METHYL]-2-CHLORO-1,3-THIAZOLE;2-chloro-5-(phenylmethanesulfonylmethyl)-1,3-thiazole;Thiazole, 2-chloro-5-[[(phenylmethyl)sulfonyl]methyl]-
CAS No.866039-47-6

Synthetic Route by SureRoute

1. ACXYPO533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFQXS732 route compound structure diagram
    ACFQXS73251793-64-7In Stock
  4. Then
  5. ACXYPO533 route product structure diagram
    ACXYPO533866039-47-6
Inquiry

2. ACXYPO533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFQXS732 route compound structure diagram
    ACFQXS73251793-64-7In Stock
  4. Then
  5. ACXYPO533 route product structure diagram
    ACXYPO533866039-47-6
Inquiry

3. ACXYPO533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXYPO533 route product structure diagram
    ACXYPO533866039-47-6
Inquiry

Comments (0)